BR0107405A - Derivados de indol que atuam como antagonistas do receptor mcp-1 - Google Patents
Derivados de indol que atuam como antagonistas do receptor mcp-1Info
- Publication number
- BR0107405A BR0107405A BR0107405-9A BR0107405A BR0107405A BR 0107405 A BR0107405 A BR 0107405A BR 0107405 A BR0107405 A BR 0107405A BR 0107405 A BR0107405 A BR 0107405A
- Authority
- BR
- Brazil
- Prior art keywords
- sup
- halo
- hydrogen
- methoxy
- lower alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"DERIVADOS DE INDOL QUE ATUAM COMO ANTAGONISTAS DO RECEPTOR MCP-1". A presente invenção se refere a um composto de fórmula (I): em que R^ 1^ é hidrogênio, halogênio, metila, etila ou metóxi; R^ 2^ é hidrogênio, halogênio, metila, etila ou metóxi; R^ 3^ é um grupo halo, alquila inferior, alquenila inferior, alquinila inferior, trifluorometila, nitro, ciano, trifluorometóxi, C(O)R^ 7^ ou S(O)~ n~R^ 7^ onde n é 0, 1 ou 2 e R^ 7^ é um grupo alquila; R^ 4^ é um grupo halo, trifluorometila, metiltio, metóxi, trifluorometóxi ou alquila inferior, alquenila inferior ou alquinila inferior; R^ 5^ é hidrogênio, halogênio, ciano, alquila inferior, alquenila inferior ou alquinila inferior ou COR^ 8^, onde R^ 8^ é alquila inferior; R^ 6^ é hidrogênio, halogênio, alquila inferior, alquinila inferior ou COR^ 9^, onde R^ 9^ é alquila inferior; desde que quando R^ 1^ for hidrogênio, halogênio ou metóxi, R^ 2^ será hidrogênio, halogênio, metila, etila ou metóxi, R^ 5^ e R^ 6^ serão ambos hidrogênio, e um de R^ 3^ e R^ 4^ for cloro, flúor ou trifluorometila, então o outro de R^ 3^ e R^ 4^ não será halogênio nem trifluorometila; ou um sal ou pró-droga farmaceuticamente aceitáveis dos mesmos. Esse compostos apresentam atividade útil no tratamento de doenças inflamatórias, especificamente ao antagonizar o efeito mediado pela MCP-1 em um animal de sangue quente, tal como o ser humano.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0000625.4A GB0000625D0 (en) | 2000-01-13 | 2000-01-13 | Chemical compounds |
PCT/GB2001/000074 WO2001051467A1 (en) | 2000-01-13 | 2001-01-09 | Indole derivatives as mcp-1 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0107405A true BR0107405A (pt) | 2002-10-08 |
Family
ID=9883550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0107405-9A BR0107405A (pt) | 2000-01-13 | 2001-01-09 | Derivados de indol que atuam como antagonistas do receptor mcp-1 |
Country Status (17)
Country | Link |
---|---|
US (1) | US6984657B1 (pt) |
EP (1) | EP1268423B1 (pt) |
JP (1) | JP2003519684A (pt) |
KR (1) | KR20020064374A (pt) |
CN (1) | CN1395564A (pt) |
AT (1) | ATE318800T1 (pt) |
AU (1) | AU779502B2 (pt) |
BR (1) | BR0107405A (pt) |
CA (1) | CA2393597A1 (pt) |
DE (1) | DE60117517T2 (pt) |
GB (1) | GB0000625D0 (pt) |
IL (1) | IL150276A0 (pt) |
MX (1) | MXPA02006612A (pt) |
NO (1) | NO20023381L (pt) |
NZ (1) | NZ519311A (pt) |
WO (1) | WO2001051467A1 (pt) |
ZA (1) | ZA200204351B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9716657D0 (en) | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
GB9902461D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
DE10022925A1 (de) * | 2000-05-11 | 2001-11-15 | Basf Ag | Substituierte Indole als PARP-Inhibitoren |
US20080076120A1 (en) * | 2006-09-14 | 2008-03-27 | Millennium Pharmaceuticals, Inc. | Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders |
WO2017163263A1 (en) | 2016-03-22 | 2017-09-28 | Council Of Scientific & Industrial Research | Indole derivatives, preparation and use thereof |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3557142A (en) | 1968-02-20 | 1971-01-19 | Sterling Drug Inc | 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters |
US3776923A (en) | 1970-01-06 | 1973-12-04 | American Cyanamid Co | 2-nitro-4-oxo-4,5,6,7-tetrahydroindole |
US3997557A (en) | 1974-04-23 | 1976-12-14 | American Hoechst Corporation | Substituted N-aminoalkylpyrroles |
US4496742A (en) | 1981-10-13 | 1985-01-29 | The Upjohn Company | Analogs of 5,6-dihydro PGI2 |
FR2537974A1 (fr) | 1982-12-16 | 1984-06-22 | Adir | Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant |
US4529724A (en) | 1983-10-11 | 1985-07-16 | Mcneilab, Inc. | 6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives |
FR2565981B1 (fr) | 1984-06-15 | 1986-09-19 | Adir | Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant |
WO1986000896A1 (en) | 1984-07-30 | 1986-02-13 | Schering Corporation | NOVEL PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA ADb BDPYRROLE-2-CARBOXYLATE |
US4675332A (en) | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
EP0189690B1 (en) | 1984-12-12 | 1989-03-01 | Merck & Co. Inc. | Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them |
US4721725A (en) | 1986-01-27 | 1988-01-26 | E. R. Squibb & Sons, Inc. | Aryl-cycloalkyl[b]pyrrole derivatives |
IL84796A (en) | 1986-12-17 | 1992-03-29 | Merck Frosst Canada Inc | Substituted n-benzyl-indoles and pharmaceutical compositions containing them |
JPS63284177A (ja) | 1987-05-14 | 1988-11-21 | Sumitomo Chem Co Ltd | ホルミルピロロピロ−ル類およびその製造方法 |
US4751231A (en) | 1987-09-16 | 1988-06-14 | Merck & Co., Inc. | Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents |
DE3907388A1 (de) | 1989-03-08 | 1990-09-13 | Kali Chemie Pharma Gmbh | Verfahren zur herstellung von indolcarbonsaeurederivaten |
NZ234883A (en) | 1989-08-22 | 1995-01-27 | Merck Frosst Canada Inc | Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof |
US5272145A (en) | 1989-08-22 | 1993-12-21 | Merck Frosst Canada, Inc. | (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes |
DE3943225A1 (de) | 1989-12-23 | 1991-06-27 | Schering Ag | Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln |
US5081145A (en) | 1990-02-01 | 1992-01-14 | Merck Frosst Canada, Inc. | Indole-2-alkanoic acids compositions of and anti allergic use thereof |
WO1992004343A1 (en) | 1990-09-04 | 1992-03-19 | Yamanouchi Pharmaceutical Co., Ltd. | Novel tetrahydrobenzazole derivative |
US5260322A (en) | 1990-10-08 | 1993-11-09 | Merck & Co., Inc. | Angiotension II antagonists in the treatment of hyperuricemia |
JPH04273857A (ja) | 1991-02-26 | 1992-09-30 | Taisho Pharmaceut Co Ltd | N−置換フェニルスルホニルインドール誘導体 |
US5290798A (en) | 1991-09-30 | 1994-03-01 | Merck Frosst Canada, Inc. | (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
US5389650A (en) | 1991-09-30 | 1995-02-14 | Merck Frosst Canada, Inc. | (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
US5308850A (en) | 1991-09-30 | 1994-05-03 | Merck Frosst Canada, Inc. | (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
US5190968A (en) | 1991-09-30 | 1993-03-02 | Merck Frosst Canada, Inc. | (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis |
CA2079374C (en) | 1991-09-30 | 2003-08-05 | Merck Frosst Canada Incorporated | (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
US5273980A (en) | 1991-09-30 | 1993-12-28 | Merck Frosst Canada Inc. | Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis |
US5318985A (en) | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
AU3488693A (en) | 1992-02-13 | 1993-09-03 | Merck Frosst Canada Inc. | (Azaaromaticalkoxy)indoles as inhibitors of leukotriene biosynthesis |
ATE197051T1 (de) | 1992-04-03 | 2000-11-15 | Upjohn Co | Pharmazeutisch wirksame bicyclisch heterocyclische amine |
US5334719A (en) | 1992-06-17 | 1994-08-02 | Merck Frosst Canada, Inc. | Bicyclic(azaaromatic)indoles as inhibitors of leukotriene bisynthesis |
US5288743A (en) | 1992-11-20 | 1994-02-22 | Abbott Laboratories | Indole carboxylate derivatives which inhibit leukotriene biosynthesis |
ZA939516B (en) | 1992-12-22 | 1994-06-06 | Smithkline Beecham Corp | Endothelin receptor antagonists |
EP0639573A1 (de) | 1993-08-03 | 1995-02-22 | Hoechst Aktiengesellschaft | Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament |
US5852046A (en) | 1993-08-03 | 1998-12-22 | Hoechst Aktiengesellschaft | Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them |
US5399699A (en) | 1994-01-24 | 1995-03-21 | Abbott Laboratories | Indole iminooxy derivatives which inhibit leukotriene biosynthesis |
CA2196046A1 (en) | 1994-07-27 | 1996-02-08 | Nigel Birdsall | Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors |
US5482960A (en) | 1994-11-14 | 1996-01-09 | Warner-Lambert Company | Nonpeptide endothelin antagonists |
US5684032A (en) | 1994-12-13 | 1997-11-04 | Smithkline Beecham Corporation | Compounds |
EA199900808A1 (ru) | 1995-04-04 | 2000-06-26 | Тексаз Байотекнолоджи Корпорейшн | Бифенилсульфонамиды и их производные, модулирующие активность эндотелина |
IT1282797B1 (it) | 1995-04-21 | 1998-03-31 | Colla Paolo | Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids |
US5639780A (en) | 1995-05-22 | 1997-06-17 | Merck Frosst Canada, Inc. | N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors |
US5604253A (en) | 1995-05-22 | 1997-02-18 | Merck Frosst Canada, Inc. | N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors |
WO1997012613A1 (en) | 1995-10-05 | 1997-04-10 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
DK0954305T3 (da) | 1996-02-26 | 2003-08-25 | Advanced Res & Tech Inst | Anvendelse af carbonanhydraseinhibitorer til behandling af maculaødem |
WO1997035572A1 (en) | 1996-03-28 | 1997-10-02 | Smithkline Beecham Corporation | Carboxylic acid indole inhibitors of chemokines |
EP0822185A1 (en) | 1996-07-31 | 1998-02-04 | Pfizer Inc. | B-3-adrenergic agonists as antidiabetic and antiobesity agents |
EP0927167A1 (en) | 1996-08-14 | 1999-07-07 | Warner-Lambert Company | 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
GB9716657D0 (en) | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
GB9716656D0 (en) | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
RU2225397C2 (ru) | 1997-12-24 | 2004-03-10 | Авентис Фарма Дойчланд Гмбх | Производные индола как ингибиторы фактора Ха |
GB9902461D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
-
2000
- 2000-01-13 GB GBGB0000625.4A patent/GB0000625D0/en not_active Ceased
-
2001
- 2001-01-09 US US10/149,101 patent/US6984657B1/en not_active Expired - Fee Related
- 2001-01-09 IL IL15027601A patent/IL150276A0/xx unknown
- 2001-01-09 WO PCT/GB2001/000074 patent/WO2001051467A1/en active IP Right Grant
- 2001-01-09 JP JP2001551849A patent/JP2003519684A/ja active Pending
- 2001-01-09 CN CN01803643A patent/CN1395564A/zh active Pending
- 2001-01-09 DE DE60117517T patent/DE60117517T2/de not_active Expired - Fee Related
- 2001-01-09 AT AT01900197T patent/ATE318800T1/de not_active IP Right Cessation
- 2001-01-09 AU AU23874/01A patent/AU779502B2/en not_active Ceased
- 2001-01-09 NZ NZ519311A patent/NZ519311A/en unknown
- 2001-01-09 CA CA002393597A patent/CA2393597A1/en not_active Abandoned
- 2001-01-09 EP EP01900197A patent/EP1268423B1/en not_active Expired - Lifetime
- 2001-01-09 MX MXPA02006612A patent/MXPA02006612A/es unknown
- 2001-01-09 BR BR0107405-9A patent/BR0107405A/pt not_active IP Right Cessation
- 2001-01-09 KR KR1020027009020A patent/KR20020064374A/ko not_active Application Discontinuation
-
2002
- 2002-05-30 ZA ZA200204351A patent/ZA200204351B/en unknown
- 2002-07-12 NO NO20023381A patent/NO20023381L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20020064374A (ko) | 2002-08-07 |
DE60117517T2 (de) | 2006-09-21 |
NO20023381D0 (no) | 2002-07-12 |
EP1268423B1 (en) | 2006-03-01 |
JP2003519684A (ja) | 2003-06-24 |
NO20023381L (no) | 2002-09-09 |
EP1268423A1 (en) | 2003-01-02 |
DE60117517D1 (de) | 2006-04-27 |
AU779502B2 (en) | 2005-01-27 |
MXPA02006612A (es) | 2002-09-30 |
AU2387401A (en) | 2001-07-24 |
CA2393597A1 (en) | 2001-07-19 |
ATE318800T1 (de) | 2006-03-15 |
US6984657B1 (en) | 2006-01-10 |
WO2001051467A1 (en) | 2001-07-19 |
CN1395564A (zh) | 2003-02-05 |
GB0000625D0 (en) | 2000-03-01 |
NZ519311A (en) | 2004-05-28 |
ZA200204351B (en) | 2003-09-01 |
IL150276A0 (en) | 2002-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003301020A8 (en) | Isoquinolinone derivatives and their use as therapeutic agents | |
MY138352A (en) | Benzothiazole derivatives | |
ATE331726T1 (de) | Adenine-derivate | |
NO20022683L (no) | Ureaforbindelser med muskarinisk reseptor-antagonistaktivitet | |
EA200200770A1 (ru) | Производные пурина | |
ATE302775T1 (de) | Carbolinderivate | |
DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
ATE346067T1 (de) | Carbolinderivate | |
ATE316962T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
DE60112306D1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
SE9903997D0 (sv) | New compounds | |
DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
UA83868C2 (ru) | Производные бензимидазолона и хиназолинона в качестве агонистов человеческих рецепторов orl1 | |
ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
BR0107405A (pt) | Derivados de indol que atuam como antagonistas do receptor mcp-1 | |
DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
RS50109B (sr) | Derivati 4-heterociklilsulfonamidil-6-metoksi-5-(2-metoksi- fenoksi)-2-piridil-piridimina, njihovo dobivanje i primena kao antagonisti endotelinskih receptora | |
DE60110124D1 (de) | Kondensierte pyrazindionderivate als pde inhibitoren | |
ATE337320T1 (de) | Indolderivate als pde5-inhibitoren | |
BR0107404A (pt) | Derivados de indol que atuam como antagonistas do receptor mcp-1 | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
MXPA03000887A (es) | Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa. | |
EA200400877A1 (ru) | 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи | |
DE60323862D1 (de) | 1,2,4-triazolderivat, verfahren zu dessen herstellung, und dieses enthaltende pharmazeutische zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 6A., 7A. E 8A. ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009. |